Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0384T
|
External heart rate and 3-axis accelerometer data recording from 15 to 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; review and interpretation only
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0384U
|
Nephrology (chronic kidney disease) carboxymethyllysine methylglyoxal hydroimidazolone and carboxyethyl lysine by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and HbA1c and estimated glomerular filtration rate (GFR) with risk score reported for predictive progression to high-stage kidney disease
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0385T
|
External heart rate and 3-axis accelerometer data recording more than 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; includes report scanning analysis with report review and interpretation by a physician or other qualified health care professional
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0385U
|
Nephrology (chronic kidney disease) apolipoprotein A4 (ApoA4) CD5 antigen-like (CD5L) and insulin-like growth factor binding protein 3 (IGFBP3) by enzyme-linked immunoassay (ELISA) plasma algorithm combining results with HDL estimated glomerular filtration rate (GFR) and clinical data reported as a risk score for developing diabetic kidney disease
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0386T
|
External heart rate and 3-axis accelerometer data recording more than 30 days to assess changes in heart rate and to monitor motion analysis for the purposes of diagnosing nocturnal epilepsy seizure events; review and interpretation only
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0386U
|
Gastroenterology (Barretts esophagus) P16 RUNX3 HPP1 and FBN1 methylation analysis prognostic and predictive algorithm reported as a risk score for progression to high-grade dysplasia or esophageal cancer
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0387T
|
Transcatheter insertion or replacement of permanent leadless pacemaker ventricular
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0387U
|
Oncology (melanoma) autophagy and beclin 1 regulator 1 (AMBRA1) and loricrin (AMLo) by immunohistochemistry formalin-fixed paraffin-embedded (FFPE) tissue report for risk of progression
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0388T
|
Transcatheter removal of permanent leadless pacemaker ventricular
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0388U
|
Oncology (non-small cell lung cancer) next-generation sequencing with identification of single nucleotide variants copy number variants insertions and deletions and structural variants in 37 cancer-related genes plasma with report for alteration detection
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0389T
|
Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis review and report leadless pacemaker system
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0389U
|
Pediatric febrile illness (Kawasaki disease [KD]) interferon alpha-inducible protein 27 (IFI27) and mast cell-expressed membrane protein 1 (MCEMP1) RNA using quantitative reverse transcription polymerase chain reaction (RT-qPCR) blood reported as a risk score for KD
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0390T
|
Peri-procedural device evaluation (in person) and programming of device system parameters before or after a surgery procedure or test with analysis review and report leadless pacemaker system
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0390U
|
Obstetrics (preeclampsia) kinase insert domain receptor (KDR) Endoglin (ENG) and retinol-binding protein 4 (RBP4) by immunoassay serum algorithm reported as a risk score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0391T
|
Interrogation device evaluation (in person) with analysis review and report includes connection recording and disconnection per patient encounter leadless pacemaker system
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0391U
|
Oncology (solid tumor) DNA and RNA by next-generation sequencing utilizing formalin-fixed paraffin-embedded (FFPE) tissue 437 genes interpretive report for single nucleotide variants splice-site variants insertions/deletions copy number alterations gene fusions tumor mutational burden and microsatellite instability with algorithm quantifying immunotherapy response score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0392T
|
Laparoscopy surgical esophageal sphincter augmentation procedure placement of sphincter augmentation device (ie magnetic band)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0392U
|
Drug metabolism (depression anxiety attention deficit hyperactivity disorder [ADHD]) gene-drug interactions variant analysis of 16 genes including deletion/duplication analysis of CYP2D6 reported as impact of gene-drug interaction for each drug
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0393T
|
Removal of esophageal sphincter augmentation device
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0393U
|
Neurology (eg Parkinson disease dementia with Lewy bodies) cerebrospinal fluid (CSF) detection of misfolded a-synuclein protein by seed amplification assay qualitative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.